In the past year, Don has helped lead the company’s efforts to enhance diversity in clinical trials participation, including shepherding development of an implementation plan specific to PhRMA’s revised clinical trials principles. Don has also represented Astellas in discussions on the reauthorization of the Prescription Drug User Fee Act (PDUFA), working to encourage an efficient
Deb consistently goes beyond her traditional day-to-day responsibilities to advance policy priorities at both the state and federal level. Her ability to simply translate complicated schematics has been invaluable in educating and engaging diverse stakeholders on some of the industry’s most pressing policy fronts — including co-pay accumulator bans, rebate pass-through and improved transparency around
Paul is a special type of researcher who can translate scientific concepts into themes and messages that resonate with non-scientists. He communicates the value of the critical work of pharmaceutical research in understandable, impactful ways to key elected officials, advocates and the public visiting Pfizer’s La Jolla, California site for many years now. Additionally, he
David and his colleague, Caroline Rosewell, were the team leaders in the company’s efforts to set up monoclonal antibody infusion clinics across the state of Indiana. These clinics not only helped get the treatment out to at-risk patients across the state, but they also served as an important tutorial and “how to” for hospitals and
(Celgene Corporation) As a “Celgene Ambassador,” Michele has been a tremendous partner to the Government Relations teams in helping them understand and communicate Celgene’s clinical trials footprint to legislators across the United States. She helped create the first Celgene State Fact Sheets to demonstrate Celgene’s presence in states across the country – an important tool
(Astellas) – Catherine selflessly volunteers her time and energies as a PAC ambassador to educate her peers on the value of supporting Astellas’ government affairs initiatives. She has also volunteered in Massachusetts state politics for 10 years and is currently an elected official in her hometown.
Caroline and her colleague, David Riggs, were the team leaders in the company’s efforts to set up monoclonal antibody infusion clinics across the state of Indiana. These clinics not only helped get the treatment out to at-risk patients across the state, but they also served as an important tutorial and “how to” for hospitals and
(GlaxoSmithKline) – Michael “Andy” Devine serves as a great role model on service to patients, to the industry and to the political process. A trained pharmacist, Andy dispenses the right messages to colleagues, senior management and elected officials alike, helping to create an environment where his colleagues and our industry can continue to succeed.
Dr. Janelle A. Sabo currently leads clinical systems, supply and innovation within the Clinical Design, Delivery, and Analytics division, enabling clinical development from early discovery through commercialization. She helped develop Indiana’s largest COVID-19 reference lab and the state’s largest drive through testing facility. Along with Chris Otto, she assisted in building a lab design strategy
The Sanofi Protein Sciences team is being recognized for their extensive engagement with federal and state legislators. When Connecticut Gov. Lamont was newly elected, the team hosted him and Lt. Gov. Bysiewicz at their Connecticut site to learn about the research and development on the COVID-19 vaccine and their flu vaccine innovative technology. Since that